AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November and December

November 4, 2019 GMT

CLEARWATER, Fla.--(BUSINESS WIRE)--Nov 4, 2019--

Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of its Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and as J-Plasma® in the hospital surgical market, announced today that management will participate in the following upcoming investor conferences:

The 10th Annual Craig-Hallum Alpha Select Conference at the Sheraton New York Times Square Hotel in New York, New York.

The Stifel 2019 Healthcare Conference at the Lotte New York Palace Hotel in New York, New York.

The31st Annual Piper Jaffray Healthcare Conference at the Lotte New York Palace in New York, New York.

Live audio webcasts of the presentations will be provided under the ‘Company Events’ section of the Apyx Medical Corporation investor relations website at https://apyxmedical.com/investor_relations/. An archive of the webcast will be available for replay following the conferences.

About Apyx Medical Corporation:

Apyx Medical Corporation (formerly Bovie Medical Corporation) is an advanced energy technology company with a passion for elevating people’s lives through innovative products in the cosmetic and surgical markets. Known for its innovative Helium Plasma Technology, Apyx is solely focused on bringing transformative solutions to the physicians and patients it serves. The company’s Helium Plasma Technology is marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion offers plastic surgeons, fascial plastic surgeons and cosmetic physicians a unique ability to provide controlled heat to the tissue to achieve their desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. The Company also leverages its deep expertise and decades of experience in unique waveforms through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191104005199/en/

CONTACT: Investor Relations:

Westwicke Partners on behalf of Apyx Medical Corporation

Mike Piccinino, CFA

investor.relations@apyxmedical.com

KEYWORD: FLORIDA NEW YORK UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: MEDICAL SUPPLIES MEDICAL DEVICES HEALTH HOSPITALS SURGERY BIOTECHNOLOGY

SOURCE: Apyx Medical Corporation

Copyright Business Wire 2019.

PUB: 11/04/2019 07:30 AM/DISC: 11/04/2019 07:31 AM

http://www.businesswire.com/news/home/20191104005199/en